Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 53

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Endocrine changes in brain death and transplantation

Ranasinghe, Aaron M., Bonser, Robert S.·2011·Best Practice & Research Clinical Endocrinology & Metabolism
DOI 10.1016/j.beem.2011.03.003
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.beem.2011.03.003

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 100

  1. Wood, 2004, Care of the potential organ donor, The New England Journal of Medicine, 351, 2730, 10.1056/NEJMra013103 · DOI
  2. Wood, 2007, Management of the potential organ donor, Transplantation Reviews, 21, 204, 10.1016/j.trre.2007.07.007 · doi:10.1016/j.trre.2007.07.007
  3. Novitzky, 1986, Prevention of myocardial injury during brain death by total cardiac sympathectomy in the Chacma baboon, Annals of Thoracic Surgery, 41, 520, 10.1016/S0003-4975(10)63032-9 · DOI
  4. Siaghy, 1998, Protective effects of labetalol on myocardial contractile function in brain-dead pigs, Transplant Proceedings, 30, 2842, 10.1016/S0041-1345(98)00833-1 · doi:10.1016/s0041-1345(98)00833-1
  5. Novitzky, 1987, Pathophysiology of pulmonary edema following experimental brain death in the chacma baboon, Annals of Thoracic Surgery, 43, 288, 10.1016/S0003-4975(10)60615-7 · doi:10.1016/s0003-4975(10)60615-7
  6. Birks, 2000, Activation of apoptotic and inflammatory pathways in dysfunctional donor hearts, Transplantation, 70, 1498, 10.1097/00007890-200011270-00018 · DOI
  7. Barklin, 2009, Systemic inflammation in the brain-dead organ donor, Acta Anaesthesiologica Scandinavica, 53, 425, 10.1111/j.1399-6576.2008.01879.x · DOI
  8. Venkateswaran, 2009, The proinflammatory environment in potential heart and lung donors: prevalence and impact of donor management and hormonal therapy, Transplantation, 88, 582, 10.1097/TP.0b013e3181b11e5d · doi:10.1097/tp.0b013e3181b11e5d
  9. Birks, 2000, Elevated tumor necrosis factor-alpha and interleukin-6 in myocardium and serum of malfunctioning donor hearts, Circulation, 102, III352
  10. Plenz, 2002, The interleukin-6/interleukin-6-receptor system is activated in donor hearts, Journal of American College of Cardiology, 39, 1508, 10.1016/S0735-1097(02)01791-6 · DOI
  11. Birks, 2001, Molecular and cellular mechanisms of donor heart dysfunction, Transplant Proceedings, 33, 2749, 10.1016/S0041-1345(01)02178-9 · doi:10.1016/s0041-1345(01)02178-9
  12. Wilhelm, 2000, Activation of the heart by donor brain death accelerates acute rejection after transplantation, Circulation, 102, 2426, 10.1161/01.CIR.102.19.2426 · doi:10.1161/01.cir.102.19.2426
  13. Deng, 2002, The role of IL6 cytokines in acute cardiac allograft rejection, Transplant Immunology, 9, 115, 10.1016/S0966-3274(02)00004-7 · DOI
  14. De Perrot, 2002, Interleukin-8 release during early reperfusion predicts graft function in human lung transplantation, American Journal of Respiratory and Critical Care Medicine, 165, 211, 10.1164/ajrccm.165.2.2011151 · DOI · Paper page
  15. Fisher, 2001, Elevated levels of interleukin-8 in donor lungs is associated with early graft failure after lung transplantation, American Journal of Respiratory and Critical Care Medicine, 163, 259, 10.1164/ajrccm.163.1.2005093 · DOI · Paper page
  16. Birks, 2000, Tumor necrosis factor-alpha is expressed in donor heart and predicts right ventricular failure after human heart transplantation, Circulation, 102, 326, 10.1161/01.CIR.102.3.326 · DOI
  17. Kellum, 2008, Feasibility study of cytokine removal by hemoadsorption in brain-dead humans, Critical Care Medicine, 36, 268, 10.1097/01.CCM.0000291646.34815.BB · DOI
  18. Venkateswaran, 2009, Donor cardiac troponin-I: a biochemical surrogate of heart function, European Journal of Cardiothoracic Surgery, 36, 286, 10.1016/j.ejcts.2009.02.031 · doi:10.1016/j.ejcts.2009.02.031
  19. Potapov, 2003, Elevated donor cardiac troponin T and procalcitonin indicate two independent mechanisms of early graft failure after heart transplantation, International Journal of Cardiology, 92, 163, 10.1016/S0167-5273(03)00083-4 · doi:10.1016/s0167-5273(03)00083-4
  20. Riou, 1995, Circulating cardiac troponin T in potential heart transplant donors, Circulation, 92, 409, 10.1161/01.CIR.92.3.409 · doi:10.1161/01.cir.92.3.409
  21. Anderson, 1994, Donor cardiac troponin-T predicts subsequent inotrope requirements following cardiac transplantation, Transplantation, 58, 1056, 10.1097/00007890-199411150-00016 · doi:10.1097/00007890-199411150-00016
  22. Potapov, 2001, Value of cardiac troponin I and T for selection of heart donors and as predictors of early graft failure, Transplantation, 71, 1394, 10.1097/00007890-200105270-00007 · doi:10.1097/00007890-200105270-00007
  23. Vijay, 1998, Donor cardiac troponin T: a marker to predict heart transplant rejection, Annals of Thoracic Surgery, 66, 1934, 10.1016/S0003-4975(98)01057-1 · doi:10.1016/s0003-4975(98)01057-1
  24. Deibert, 2000, Reversible left ventricular dysfunction associated with raised troponin I after subarachnoid haemorrhage does not preclude successful heart transplantation, Heart, 84, 205, 10.1136/heart.84.2.205 · doi:10.1136/heart.84.2.205
  25. Khush, 2007, Donor cardiac troponin I levels do not predict recipient survival after cardiac transplantation, Journal of Heart and Lung Transplantation, 26, 1048, 10.1016/j.healun.2007.07.026 · doi:10.1016/j.healun.2007.07.026
  26. Boccheciampe, 2009, Serum troponin Ic values in organ donors are related to donor myocardial dysfunction but not to graft dysfunction or rejection in the recipients, International Journal of Cardiology, 133, 80, 10.1016/j.ijcard.2007.12.006 · doi:10.1016/j.ijcard.2007.12.006
  27. Koiv, 1997, Changes of sympatho-adrenal and hypothalamo-pituitary-adrenocortical system in patients with head injury, Acta Neurologica Scandinavica, 96, 52, 10.1111/j.1600-0404.1997.tb00238.x · DOI
  28. Arafah, 2006, Hypothalamic pituitary adrenal function during critical illness: limitations of current assessment methods, Journal of Clinical Endocrinology and Metabolism, 91, 3725, 10.1210/jc.2006-0674 · DOI · Paper page
  29. Van den Berghe, 1998, Acute and prolonged critical illness as different neuroendocrine paradigms, Journal of Clinical Endocrinology and Metabolism, 83, 1827
  30. Chen, 1996, Hormonal and hemodynamic changes in a validated animal model of brain death, Critical Care Medicine, 24, 1352, 10.1097/00003246-199608000-00014 · doi:10.1097/00003246-199608000-00014
  31. Venkateswaran, 2009, The haemodynamic effects of adjunctive hormone therapy in potential heart donors: a prospective randomized double-blind factorially designed controlled trial, European Heart Journal, 30, 1771, 10.1093/eurheartj/ehp086 · doi:10.1093/eurheartj/ehp086
  32. Taniguchi, 1992, Effects of hormonal supplements on the maintenance of cardiac function in potential donor patients after cerebral death, European Journal of Cardiothoracic Surgery, 6, 96, 10.1016/1010-7940(92)90082-9 · DOI
  33. Sebening, 1995, Cardiocirculatory effects of acutely increased intracranial pressure and subsequent brain death, European Journal of Cardiothoracic Surgery, 9, 360, 10.1016/S1010-7940(05)80168-X · doi:10.1016/s1010-7940(05)80168-x
  34. Sakagoshi, 1992, Serial changes in myocardial beta-adrenergic receptor after experimental brain death in dogs, Journal of Heart and Lung Transplantation, 11, 1054
  35. Schnuelle, 2001, Effects of catecholamine application to brain-dead donors on graft survival in solid organ transplantation, Transplantation, 72, 455, 10.1097/00007890-200108150-00017 · DOI
  36. Venkateswaran, 2010, Echocardiography in the potential heart donor, Transplantation, 89, 894, 10.1097/TP.0b013e3181cfe8e9 · doi:10.1097/tp.0b013e3181cfe8e9
  37. Mukadam, 2005, Does donor catecholamine administration affect early lung function after transplantation?, Journal of Thoracic and Cardiovascular Surgery, 130, 926, 10.1016/j.jtcvs.2005.02.007 · doi:10.1016/j.jtcvs.2005.02.007
  38. Schnuelle, 2009, Effects of donor pretreatment with dopamine on graft function after kidney transplantation, JAMA: The Journal of the American Medical Association, 302, 1067, 10.1001/jama.2009.1310 · doi:10.1001/jama.2009.1310
  39. Smith, 2004, Physiologic changes during brain stem death–lessons for management of the organ donor, Journal of Heart and Lung Transplantation, 23, S217, 10.1016/j.healun.2004.06.017 · doi:10.1016/j.healun.2004.06.017
  40. Stocker, 2000, Intensive care of the multiorgan donor, European Journal of Trauma, 26, 53, 10.1007/s000680050001 · doi:10.1007/s000680050001
  41. Pennefather, 1995, Use of low dose arginine vasopressin to support brain-dead organ donors, Transplantation, 59, 58, 10.1097/00007890-199501150-00011 · doi:10.1097/00007890-199501150-00011
  42. Chen, 1999, Vasopressin deficiency and pressor hypersensitivity in hemodynamically unstable organ donors, Circulation, 100, 244
  43. Vermes, 2001, The hypothalamic-pituitary-adrenal response to critical illness, Best Practice & Research Clinical Endocrinology and Metabolism, 15, 495, 10.1053/beem.2001.0166 · DOI
  44. Dimopoulou, 2003, High prevalence of decreased cortisol reserve in brain-dead potential organ donors, Critical Care Medicine, 31, 1113, 10.1097/01.CCM.0000059644.54819.67 · DOI
  45. Amado, 1995, Blood levels of cytokines in brain-dead patients: relationship with circulating hormones and acute-phase reactants, Metabolism, 44, 812, 10.1016/0026-0495(95)90198-1 · DOI
  46. Lopau, 2000, Hormonal changes in brain death and immune activation in the donor, Transplant International, 13, S282, 10.1007/s001470050342 · doi:10.1007/s001470050342
  47. Powner, 1990, Hormonal changes in brain dead patients, Critical Care Medicine, 18, 702, 10.1097/00003246-199007000-00004 · doi:10.1097/00003246-199007000-00004
  48. Follette, 1998, Improved oxygenation and increased lung donor recovery with high-dose steroid administration after brain death, Journal of Heart and Lung Transplantation, 17, 423
  49. Lyons, 2005, Glucocorticoid administration reduces cardiac dysfunction after brain death in pigs, Journal of Heart and Lung Transplantation, 24, 2249, 10.1016/j.healun.2005.07.010 · doi:10.1016/j.healun.2005.07.010
  50. McLean, 2007, Glucocorticoids alter the balance between pro- and anti-inflammatory mediators in the myocardium in a porcine model of brain death, Journal of Heart and Lung Transplantation, 26, 78, 10.1016/j.healun.2006.10.011 · DOI
  51. Nicolas-Robin, 2010, Hydrocortisone supplementation enhances hemodynamic stability in brain-dead patients, Anesthesiology, 112, 1204, 10.1097/ALN.0b013e3181d4f34d · DOI
  52. Venkateswaran, 2008, Early donor management increases the retrieval rate of lungs for transplantation, Annals of Thoracic Surgery, 85, 278, 10.1016/j.athoracsur.2007.07.092 · DOI
  53. Kotsch, 2008, Methylprednisolone therapy in deceased donors reduces inflammation in the donor liver and improves outcome after liver transplantation: a prospective randomized controlled trial, Annals of Surgery, 248, 1042, 10.1097/SLA.0b013e318190e70c · DOI
  54. Kainz, 2010, Steroid pretreatment of organ donors to prevent postischemic renal allograft failure, Annals of Internal Medicine, 153, 222, 10.7326/0003-4819-153-4-201008170-00003 · DOI
  55. Warner, 2010, Mechanisms behind the non-thyroidal illness syndrome: an update, Journal of Endocrinology, 205, 1, 10.1677/JOE-09-0412 · DOI · Paper page
  56. Chopra, 1985, Evidence for an inhibitor of extrathyroidal conversion of thyroxine to 3,5,3’-triiodothyronine in sera of patients with nonthyroidal illnesses, Journal of Clinical Endocrinology Metabolism, 60, 666, 10.1210/jcem-60-4-666 · DOI
  57. Van den, 2001, The neuroendocrine response to stress is a dynamic process, Best Practice & Research Clinical Endocrinology and Metabolism, 15, 405, 10.1053/beem.2001.0160 · DOI
  58. Chopra, 1997, Euthyroid sick syndrome: is it a misnomer?, Journal of Clinical Endocrinology Metabolism, 82, 329, 10.1210/jcem.82.2.3745 · DOI · Paper page
  59. Novitzky, 1987, Hemodynamic and metabolic responses to hormonal therapy in brain-dead potential organ donors, Transplantation, 43, 852, 10.1097/00007890-198743060-00016 · doi:10.1097/00007890-198743060-00016 · Paper page
  60. Randell, 1992, Triiodothyronine treatment in brain-dead multiorgan donors–a controlled study, Transplantation, 54, 736, 10.1097/00007890-199210000-00034 · doi:10.1097/00007890-199210000-00034
  61. Jeevanandam, 1994, Reversal of donor myocardial dysfunction by triiodothyronine replacement therapy, Journal of Heart & Lung Transplantation, 13, 681
  62. Jeevanandam, 1997, Triiodothyronine: spectrum of use in heart transplantation, Thyroid, 7, 139, 10.1089/thy.1997.7.139 · doi:10.1089/thy.1997.7.139
  63. Wheeldon, 1995, Transforming the "unacceptable" donor: outcomes from the adoption of a standardized donor management technique, Journal of Heart and Lung Transplantation, 14, 734
  64. Roels, 2000, Effect of triiodothyronine replacement therapy on maintenance characteristics and organ availability in hemodynamically unstable donors, Transplant Proceedings, 32, 1564, 10.1016/S0041-1345(00)01331-2 · doi:10.1016/s0041-1345(00)01331-2
  65. Salim, 2007, Using thyroid hormone in brain-dead donors to maximize the number of organs available for transplantation, Clinical Transplantation, 21, 405, 10.1111/j.1399-0012.2007.00659.x · doi:10.1111/j.1399-0012.2007.00659.x
  66. Novitzky, 1987, Improved cardiac function following hormonal therapy in brain dead pigs: relevance to organ donation, Cryobiology, 24, 1, 10.1016/0011-2240(87)90002-2 · doi:10.1016/0011-2240(87)90002-2
  67. Novitzky, 2006, Hormonal therapy of the brain-dead organ donor: experimental and clinical studies, Transplantation, 82, 1396, 10.1097/01.tp.0000237195.12342.f1 · doi:10.1097/01.tp.0000237195.12342.f1
  68. Cooper, 2009, A review of studies relating to thyroid hormone therapy in brain-dead organ donors, Frontiers in Bioscience, 14, 3750, 10.2741/3486 · DOI
  69. Goarin, 1996, The effects of triiodothyronine on hemodynamic status and cardiac function in potential heart donors, Anesthesia Analgesia, 83, 41, 10.1213/00000539-199607000-00008 · DOI
  70. Rosendale, 2003, Hormonal resuscitation yields more transplanted hearts, with improved early function, Transplantation, 75, 1336, 10.1097/01.TP.0000062839.58826.6D · doi:10.1097/01.tp.0000062839.58826.6d
  71. Rosendale, 2003, Aggressive pharmacologic donor management results in more transplanted organs, Transplantation, 75, 482, 10.1097/01.TP.0000045683.85282.93 · doi:10.1097/01.tp.0000045683.85282.93
  72. Brent, 1986, Thyroxine therapy in patients with severe nonthyroidal illnesses and low serum thyroxine concentration, Journal of Clinical Endocrinology Metabolism, 63, 1, 10.1210/jcem-63-1-1 · DOI · Paper page
  73. Votapka, 1996, Effect of triiodothyronine on graft function in a model of heart transplantation, Annals of Thoracic Surgery, 62, 78, 10.1016/0003-4975(96)00238-X · DOI
  74. Hing, 2007, The effects of hormone resuscitation on cardiac function and hemodynamics in a porcine brain-dead organ donor model, American Journal of Transplantation, 7, 809, 10.1111/j.1600-6143.2007.01735.x · doi:10.1111/j.1600-6143.2007.01735.x
  75. James, 2010, The effects of acute triiodothyronine therapy on myocardial gene expression in brain stem dead cardiac donors, Journal of Clinical Endocrinology and Metabolism, 95, 1338, 10.1210/jc.2009-1659 · DOI
  76. Quinn, 2006, Improved myocardial protection during coronary artery surgery with glucose-insulin-potassium: a randomized controlled trial, The Journal of Thoracic and Cardiovascular Surgery, 131, 34, 10.1016/j.jtcvs.2005.05.057 · DOI
  77. Ranasinghe, 2006, Glucose-insulin-potassium and tri-iodothyronine individually improve hemodynamic performance and are associated with reduced troponin i release after on-pump coronary artery bypass grafting, Circulation, 114, I-245
  78. Howell, 2011, Glucose-insulin-potassium reduces the incidence of low cardiac output episodes after aortic valve replacement for aortic stenosis in patients with left ventricular hypertrophy: results from the hypertrophy, insulin, glucose, and electrolytes (hinge) trial, Circulation
  79. Okamoto, 1986, Reperfusate composition: interaction of marked hyperglycemia and marked hyperosmolarity in allowing immediate contractile recovery after four hours of regional ischemia, Journal of Thoracic & Cardiovascular Surgery, 92
  80. Wisneski, 1990, Effects of acute hyperglycemia on myocardial glycolytic activity in humans, Journal of Clinical Investigation, 85, 1648, 10.1172/JCI114616 · DOI
  81. Iyengar, 1976, Myocardial glycogen in prevention of perioperative ischemic injury of the heart: a preliminary report, Canadian Journal of Surgery, 19, 246
  82. Lolley, 1979, Importance of preoperative myocardial glycogen levels in human cardiac preservation: preliminary report, The Journal of Thoracic and Cardiovascular Surgery, 78, 678, 10.1016/S0022-5223(19)38054-7 · doi:10.1016/s0022-5223(19)38054-7
  83. Goodwin, 1998, Energy provision from glycogen, glucose, and fatty acids on adrenergic stimulation of isolated working rat hearts, AJP – Heart and Circulatory Physiology, 274, H1239, 10.1152/ajpheart.1998.274.4.H1239 · DOI
  84. Neely, 1975, Effect of coronary blood flow on glycolytic flux and intracellular pH in isolated rat hearts, Circulation Research, 37, 733, 10.1161/01.RES.37.6.733 · DOI
  85. Wittnich, 1984, Myocardial protection: heparin-induced free fatty acid elevation during cardiopulmonary bypass and its prevention, Journal of Surgical Research, 36, 527, 10.1016/0022-4804(84)90137-9 · doi:10.1016/0022-4804(84)90137-9
  86. McDaniel, 1988, Myocardial fuel and energy balance, acute ischemia and diabetes, American Journal of Medical Sciences, 295, 207, 10.1097/00000441-198803000-00008 · doi:10.1097/00000441-198803000-00008
  87. Nilsson, 1994, Glucose-insulin-potassium (GIK) prevents derangement of myocardial metabolism in brain-dead pigs, European Journal of Cardiothoracic Surgery, 8, 442, 10.1016/1010-7940(94)90087-6 · doi:10.1016/1010-7940(94)90087-6
  88. Russell, 1991, Changes in citric acid cycle flux and anaplerosis antedate the functional decline in isolated rat hearts utilizing acetoacetate, Journal of Clinical Investigation, 87, 384, 10.1172/JCI115008 · DOI
  89. Baron, 1993, Insulin differentially regulates systemic and skeletal muscle vascular resistance, American Journal of Physiology, 265, t-7
  90. Jonassen, 2000, Glucose-insulin-potassium reduces infarct size when administered during reperfusion, Cardiovascular Drugs and Therapy, 14, 615, 10.1023/A:1007802630604 · doi:10.1023/a:1007802630604
  91. Jonassen, 2000, Insulin administered at reoxygenation exerts a cardioprotective effect in myocytes by a possible anti-apoptotic mechanism, Journal of Molecular and Cellular Cardiology, 32, 757, 10.1006/jmcc.2000.1118 · DOI
  92. Jonassen, 2001, Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling, Circulation Research, 89, 1191, 10.1161/hh2401.101385 · DOI · Paper page
  93. Tiron, 2006, p38 MAPK appears to be involved in the cytoprotective effect of insulin therapy administrated at reperfusion, Journal of Molecular and Cellular Cardiology, 40, 973, 10.1016/j.yjmcc.2006.03.158 · doi:10.1016/j.yjmcc.2006.03.158
  94. von Lewinski, 2005, Insulin causes [Ca2+]i-dependent and [Ca2+]i-independent positive inotropic effects in failing human myocardium, Circulation, 111, 2588, 10.1161/CIRCULATIONAHA.104.497461 · DOI
  95. Ferrara, 2005, Insulin-induced changes in [beta]-adrenergic response: an experimental study in the isolated rat papillary muscle, American Journal of Hypertension, 18, 348, 10.1016/j.amjhyper.2004.10.006 · doi:10.1016/j.amjhyper.2004.10.006
  96. Ranasinghe, 2006, How does glucose insulin potassium improve hemodynamic performance?: evidence for altered expression of beta-adrenoreceptor and calcium handling genes, Circulation, 114, I-239
  97. van den, 2001, Intensive insulin therapy in the critically ill patients [see comment], New England Journal of Medicine, 345, 1359, 10.1056/NEJMoa011300 · DOI · Paper page
  98. Nicolas-Robin, 2008, Effect of glucose-insulin-potassium in severe acute heart failure after brain death, Critical Care Medicine, 36, 2740, 10.1097/CCM.0b013e318186f64b · DOI
  99. Blasi-Ibanez, 2009, Predictors associated with terminal renal function in deceased organ donors in the intensive care unit, Anesthesiology, 110, 333, 10.1097/ALN.0b013e318194ca8a · doi:10.1097/aln.0b013e318194ca8a
  100. Ranasinghe, 2010, Thyroid hormone in cardiac surgery, Vascular Pharmacology, 52, 131, 10.1016/j.vph.2009.11.004 · DOI

Cited by

Metadata

Authors
Ranasinghe, A. M., & Bonser, R. S.
Venue
Best Practice & Research Clinical Endocrinology & Metabolism
Publisher
Elsevier BV
Published
2011-10
Volume
25
Issue
5
Pages
799-812
ISSN
1521-690X
DOI
10.1016/j.beem.2011.03.003
Cited by
53
References
4
Language
en
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.